Roche’s virtual Neuroscience Update IR Event
Roche has hosted a virtual event on Monday, 30 October 2023.
| Agenda | |
|---|---|
| Welcome | Bruno Eschli, Head of Investor Relations |
| Neuroscience Strategy Update | Paulo Fontoura, SVP and Global Head of Neuroscience, Immunology, Ophthalmology, Infectious and Rare Diseases Clinical Development |
| MS - ECTRIMS data review | Stephen L. Hauser, Director, UCSF Weill Institute of Neurosciences |
| AD - CTAD data review | Luka Kulic, Therapeutic Area Leader Dementias, Medical Director Neuroscience and Rare Diseases |
| Q&A |
Webinar Replay
Investors